News

Tunlametinib: Targeted Breakthrough In Melanoma Therapy

tunlametinib cover

Tunlametinib is a drug used to treat cancer. It is an inhibitor of mitogen-activated protein kinase kinase. In China,tunlametinib was approved in 2024 for the treatment of NRAS mutant advanced melanoma patients who had previously…

Susoctocog Alfa: New Era Of Acquired Hemophilia Treatment

susoctocog alfa cover

The product name of Susoctocog alfa is Obizur, which is a medication used to treat bleeding episodes in adult-acquired haemophilia. Acquired haemophilia is a hemorrhagic disease characterized by the inactivation of factor VIII due to…

Urea Ointment: A New Multifunctional Favorite for Skin Care

As people’s concern for skin health increases, urea ointment, as a highly effective skincare product, is gradually entering the public eye. Its unique moisturizing, exfoliating and repairing effects make it a commonly recommended choice for…